Difference between revisions of "Team:ICT-Mumbai/Parts"

 
(16 intermediate revisions by 2 users not shown)
Line 43: Line 43:
 
/* First image (Logo. Full height) */
 
/* First image (Logo. Full height) */
 
.bgimg-1 {
 
.bgimg-1 {
     background-image: url("");
+
     background-image: url("https://static.igem.org/mediawiki/2017/d/d5/PARTS.png");
     min-height: 1000px;
+
     min-height: 500px;
 
      
 
      
 
}
 
}
Line 73: Line 73:
 
     </a>
 
     </a>
  
   <a href="https://2017.igem.org/Team:ICT-Mumbai#home" class="w3-bar-item w3-button w3-hide-small"><i class="fa fa-home" aria-hidden="true"></i>
+
   <a href="https://2017.igem.org/Team:ICT-Mumbai" class="w3-bar-item w3-button w3-hide-small"><i class="fa fa-home" aria-hidden="true"></i>
 
Home</a>
 
Home</a>
  
Line 109: Line 109:
 
  Safety</a>
 
  Safety</a>
  
<a href="https://2017.igem.org/Team:ICT-Mumbai/HP" class="w3-bar-item w3-button w3-hide-small"><i class="fa fa-handshake-o" aria-hidden="true"></i>
+
<a href="https://2017.igem.org/Team:ICT-Mumbai/HP/Gold_Integrated" class="w3-bar-item w3-button w3-hide-small"><i class="fa fa-handshake-o" aria-hidden="true"></i>
 
Human Practices</a>
 
Human Practices</a>
  
Line 139: Line 139:
  
 
<p style="height:70 px; font-family:'Lato'; font-size:20px; colour:lightgrey;">
 
<p style="height:70 px; font-family:'Lato'; font-size:20px; colour:lightgrey;">
Our project involves metabolism of ammonia by Escherichia coli to produce a blue-coloured dye,
+
Our project involves metabolism of ammonia by <i>Escherichia coli</i> to produce a blue-coloured dye,
 
indigoidine. We had to choose between using a constitutive and an inducible promoter to drive
 
indigoidine. We had to choose between using a constitutive and an inducible promoter to drive
expression of the genes that we wish to express in E. coli.</p>
+
expression of the genes that we wish to express in <i>E. coli</i>.</p>
  
 
<p style="height:70 px; font-family:'Lato'; font-size:20px; colour:lightgrey;">Expression from inducible promoters requires addition of an inducing molecule. However, as it would be
 
<p style="height:70 px; font-family:'Lato'; font-size:20px; colour:lightgrey;">Expression from inducible promoters requires addition of an inducing molecule. However, as it would be
cumbersome and tedious to add the inducer to the device that will house the engineered E. coli, and as
+
cumbersome and tedious to add the inducer to the device that will house the engineered <i>E. coli</i>, and as
 
it would also contribute to the cost, we decided to use a constitutive promoter to drive gene expression.</p>
 
it would also contribute to the cost, we decided to use a constitutive promoter to drive gene expression.</p>
  
Line 152: Line 152:
 
promoters were ruled out as possible choices.</p>
 
promoters were ruled out as possible choices.</p>
  
<p style="height:70 px; font-family:'Lato'; font-size:20px; colour:lightgrey;">The ychH promoter has been described in literature to be active under low glucose conditions (Ref. 1).
+
<p style="height:70 px; font-family:'Lato'; font-size:20px; colour:lightgrey;">The <i>ychH</i> promoter has been described in literature to be active under low glucose conditions (Ref. 1). Crp acts as a positive transcription regulator of <i>ychH</i>, which means that this gene is expressed when glucose concentrations are low (Ref. 2; <a href="https://ecocyc.org/"><mark>EcoCyc database</mark></a>). Moreover, it is not a very strong promoter, compared to those frequently employed to express recombinant proteins in <i>E. coli</i> (Ref. 3). Therefore, the <i>ychH</i> promoter became our promoter of choice.</p>
Moreover, it is not a very strong promoter, compared to those frequently employed to express
+
recombinant proteins in E. coli (Ref. 2). Therefore, the ychH promoter became our promoter of choice.</p>
+
 
+
 
+
  
 +
<br>
  
 
<!--<div class="column full_size">
 
<!--<div class="column full_size">
<h1>Parts</h1>
+
<p style="height:70 px;  font-family:'Lato';  font-size:20px; colour:lightgrey;">Parts</p>
  
 
<p>Each team will make new parts during iGEM and will submit them to the Registry of Standard Biological Parts. The iGEM software provides an easy way to present the parts your team has created. The <code>&lt;groupparts&gt;</code> tag (see below) will generate a table with all of the parts that your team adds to your team sandbox.</p>
 
<p>Each team will make new parts during iGEM and will submit them to the Registry of Standard Biological Parts. The iGEM software provides an easy way to present the parts your team has created. The <code>&lt;groupparts&gt;</code> tag (see below) will generate a table with all of the parts that your team adds to your team sandbox.</p>
 
<p>Remember that the goal of proper part documentation is to describe and define a part, so that it can be used without needing to refer to the primary literature. Registry users in future years should be able to read your documentation and be able to use the part successfully. Also, you should provide proper references to acknowledge previous authors and to provide for users who wish to know more.</p>
 
<p>Remember that the goal of proper part documentation is to describe and define a part, so that it can be used without needing to refer to the primary literature. Registry users in future years should be able to read your documentation and be able to use the part successfully. Also, you should provide proper references to acknowledge previous authors and to provide for users who wish to know more.</p>
 
  
 
</div>
 
</div>
 
 
 
 
  
 
<div class="column half_size">
 
<div class="column half_size">
Line 226: Line 218:
 
</div>-->
 
</div>-->
  
<div class="column full_size">
+
<!--<div class="column full_size">
<h5>Part Table </h5>
+
<h5>Part Table </h5>-->
 +
 
 +
<div class="w3-content w3-container w3-padding-64" id="about">
 +
  <h5 class="w3-center" style="color:#000080">Part Table</h5>
 +
 
 +
<style>
 +
h5{
 +
    line-height: 120%;
 +
}
 +
 
 +
h5 {
 +
    font-size: 30px;
 +
}
 +
 
 +
</style>
  
 
<!--<p>Please include a table of all the parts your team has made during your project on this page. Remember part characterization and measurement data must go on your team part pages on the Registry. </p>-->
 
<!--<p>Please include a table of all the parts your team has made during your project on this page. Remember part characterization and measurement data must go on your team part pages on the Registry. </p>-->
  
 
<div class="highlight">
 
<div class="highlight">
 
  
 
</html>
 
</html>
 +
<center>
 
<groupparts>iGEM17 ICT-Mumbai</groupparts>
 
<groupparts>iGEM17 ICT-Mumbai</groupparts>
 
+
</center>
 
<html>
 
<html>
 
</div>
 
</div>
Line 244: Line 250:
 
<div>
 
<div>
  
<p style="height:70 px; font-family:'Lato'; font-size:20px; colour:lightgrey;">References</p>
+
<br>
<p style="height:70 px; font-family:'Lato'; font-size:20px; colour:lightgrey;">
+
1. Hollands K, Busby SJ, Lloyd GS (2007). New targets for the cyclic AMP receptor protein in the Escherichia coli K-12 genome. FEMS Microbiol Lett 274:89-94. PMID: 17608696</p>
+
<p style="height:70 px; font-family:'Lato'; font-size:20px; colour:lightgrey;">2. Deb SS, Reshamwala SMS, Lali AM (2016). A series of template plasmids for Escherichia coli genome engineering. J Microbiol Methods 125:49-57. PMID: 27071533</p>
+
 
+
  
 +
<p style="height:70 px;  font-family:'Lato';  font-size:20px; colour:lightgrey;"><b>References</b></p>
 +
<ol>
 +
<li>Hollands K, Busby SJ, Lloyd GS (2007). New targets for the cyclic AMP receptor protein in the Escherichia coli K-12 genome. FEMS Microbiol Lett 274:89-94. PMID: 17608696</li>
 +
<li>Keseler IM, Mackie A, Peralta-Gil M, Santos-Zavaleta A, Gama-Castro S, Bonavides-Martínez C, Fulcher C, Huerta AM, Kothari A, Krummenacker M, Latendresse M, Muñiz-Rascado L, Ong Q, Paley S, Schröder I, Shearer AG, Subhraveti P, Travers M, Weerasinghe D, Weiss V, Collado-Vides J, Gunsalus RP, Paulsen I, Karp PD (2013). EcoCyc: fusing model organism databases with systems biology. Nucleic Acids Res 41(Database issue):D605-612. PMID: 23143106</li>
 +
<li>Deb SS, Reshamwala SMS, Lali AM (2016). A series of template plasmids for Escherichia coli genome engineering. J Microbiol Methods 125:49-57. PMID: 27071533</li>
 +
</ol>
 +
</p>
  
  
 
</html>
 
</html>

Latest revision as of 21:50, 1 November 2017

ICT-Mumbai 2017

Our project involves metabolism of ammonia by Escherichia coli to produce a blue-coloured dye, indigoidine. We had to choose between using a constitutive and an inducible promoter to drive expression of the genes that we wish to express in E. coli.

Expression from inducible promoters requires addition of an inducing molecule. However, as it would be cumbersome and tedious to add the inducer to the device that will house the engineered E. coli, and as it would also contribute to the cost, we decided to use a constitutive promoter to drive gene expression.

We reasoned that the constitutive promoter of choice should have the following two properties: (1) it should not be a very strong promoter, so as to not lead to any toxicity to the cell, and (2) it should be active in low-nutrient conditions. Based on these two considerations, the commonly used glycolytic promoters were ruled out as possible choices.

The ychH promoter has been described in literature to be active under low glucose conditions (Ref. 1). Crp acts as a positive transcription regulator of ychH, which means that this gene is expressed when glucose concentrations are low (Ref. 2; EcoCyc database). Moreover, it is not a very strong promoter, compared to those frequently employed to express recombinant proteins in E. coli (Ref. 3). Therefore, the ychH promoter became our promoter of choice.


Part Table

<groupparts>iGEM17 ICT-Mumbai</groupparts>


References

  1. Hollands K, Busby SJ, Lloyd GS (2007). New targets for the cyclic AMP receptor protein in the Escherichia coli K-12 genome. FEMS Microbiol Lett 274:89-94. PMID: 17608696
  2. Keseler IM, Mackie A, Peralta-Gil M, Santos-Zavaleta A, Gama-Castro S, Bonavides-Martínez C, Fulcher C, Huerta AM, Kothari A, Krummenacker M, Latendresse M, Muñiz-Rascado L, Ong Q, Paley S, Schröder I, Shearer AG, Subhraveti P, Travers M, Weerasinghe D, Weiss V, Collado-Vides J, Gunsalus RP, Paulsen I, Karp PD (2013). EcoCyc: fusing model organism databases with systems biology. Nucleic Acids Res 41(Database issue):D605-612. PMID: 23143106
  3. Deb SS, Reshamwala SMS, Lali AM (2016). A series of template plasmids for Escherichia coli genome engineering. J Microbiol Methods 125:49-57. PMID: 27071533